Table 1.
Variable | Variables (mean ± SD) | Range |
---|---|---|
Age (years) | 60.6 ± 8.7 | (22, 88) |
BMI | 28.3 ± 5.6 | |
Liver stiffness (kPa) | 14.0 ± 11.2 | (2.9, 75) |
CAP (dB/m) | 260.4 ± 64.2 | (100, 495) |
Variables (n, %) | ||
Sex | ||
Male | 1479 (96) | |
Female | 62 (4) | |
Race | ||
Black | 983 (71) | |
White | 384 (28) | |
Other | 21 (1) | |
Ethnicity | ||
Hispanic | 11 (1) | |
Non-Hispanic | 1382 (99) | |
Hypertension | ||
Yes | 1309 (85) | |
No | 229 (15) | |
Diabetes | ||
Yes | 508 (33) | |
No | 1030 (67) | |
History of smoking | ||
Yes | 1290 (85) | |
No | 232 (15) | |
Heavy drinking | ||
Yes | 377 (25) | |
No | 1147 (75) | |
HIV infection | ||
Yes | 76 (5) | |
No | 1316 (95) | |
HBV infection | ||
Yes | 60 (4) | |
No | 1423 (96) | |
HCV exposure | ||
Yes | 1318 (87) | |
No | 191 (13) | |
Fibrosis stage | ||
F1 | 368 (24) | |
F2 | 220 (14) | |
F3 | 320 (21) | |
F4 | 632 (41) | |
CAP grade | ||
Minimal | 290 (41) | |
S1 | 97 (14) | |
fS2 | 97 (14) | |
S3 | 222 (31) | |
Elastography indication | ||
HCV evaluation | 1260 (82) | |
HBV evaluation | 53 (3) | |
Fatty liver assessment | 149 (10) | |
Other | 72 (5) |
BMI, body mass index; kPa, kilopascals; CAP, controlled attenuation parameter; HIV, human immunodeficiency virus; HBV, hepatitis B virus; HCV, hepatitis C virus.